2019 is the year of the fight against thrombocytopenia

2019 is the year of the fight against thrombocytopenia

In 2019, «Yuria-Pharm» announced the year for the fight against thrombocytopenia. Regarding this company, an appropriate program was started, in which cancer and hematologic departments throughout Ukraine received recombinant human thrombopoietin (EMAPLUG) as charitable aid for patients with thrombocytopenia. Many readers of the medical newspaper “News of Medicine and Pharmacy” will be interesting to learn more about the problem of thrombocytopenia in Ukraine.

16 April, 2019
Л. Ончул

Learn more

Uncategorized

Vascular neurological complications in patients with COVID-19

Uncategorized

Astenic syndrome in a post-covid-19 patient (review and own experience)

Among the symptoms and syndromes that dominate the clinical picture of postcoid syndrome (POST-COVID-19), the signs of asthenia, increased fatigue, excessive exhaustion during normal daily activities, which form asthenic syndrome, are highlighted. For the treatment of postcoid asthenic syndrome, a combination of pathogenetically justified agents has been proposed: podaravone (Xavron), a mixture of L-arginine and...
Uncategorized

” Long-haulers “: patients with post-covid syndrome in routine clinical practice

At the beginning of the COVID 19 pandemic, SARS-CoV 2 disease was thought to be transient (like most respiratory viral infections). The World Health Organization later reported that the duration of a new coronavirus disease from the onset of the first symptoms to mild clinical recovery is ≈2 weeks, and in severe or moderate cases,...